Cargando…
Efficacy and Safety of Dupilumab in Moderate-to-Severe Bullous Pemphigoid
BACKGROUND: Bullous pemphigoid (BP) is an autoimmune blistering disorder that predominantly affects the elderly. As the main treatment for BP, systemic corticosteroids are often limited by their side effects. Safer treatment modalities are therefore needed. Dupilumab is a biologic agent used to trea...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552038/ https://www.ncbi.nlm.nih.gov/pubmed/34721404 http://dx.doi.org/10.3389/fimmu.2021.738907 |